StockDrifts LogoStockDrifts

K Bio Labs 038530

Company
케이바이오랩스K Bio Labs
Insiders
0
Buys
0
Total Value
Avg Return
Last Filing
2026-04-16

K Bio Labs (038530) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for K Bio Labs is dated 2026-04-16; the most recent is 2026-04-16. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-08-17BUYMarket Buy
미래아이앤지
Mirae I&G
-26.0K---
2026-08-14BUYMarket Buy
미래아이앤지
Mirae I&G
-38.3K₩1,082+0.0%₩42M ($29K)
2026-08-13BUYMarket Buy
미래아이앤지
Mirae I&G
-82.1K₩1,088-0.6%₩92M ($64K)
2026-08-12BUYMarket Buy
미래아이앤지
Mirae I&G
-100.5K₩1,053+2.8%₩110M ($77K)
2026-08-11BUYMarket Buy
미래아이앤지
Mirae I&G
-112.2K₩1,078+0.4%₩119M ($82K)
2026-08-03BUYMarket Buy
미래아이앤지
Mirae I&G
-723.3K₩951+9.5%₩688M ($478K)
2026-04-16SELL주식병합
미래아이앤지
Mirae I&G
--25.5M₩310+0.0%₩7.9B ($5.5M)
2026-04-16SELL주식병합
판타지오
Fantagio
--5.1M₩310+0.0%₩1.6B ($1.1M)

Frequently asked questions

Who has been buying K Bio Labs stock?
0 distinct insiders have filed 0 disclosed insider purchases in K Bio Labs (038530), most recently on 2026-04-16. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does K Bio Labs have?
K Bio Labs has 0 buy-side and 0 sell-side disclosures on record, spanning 2026-04-16 to 2026-04-16.
Where does StockDrifts get K Bio Labs insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for K Bio Labs. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.